Reports for GE HEALTHCARE CANADA INC
Company Name
GE HEALTHCARE CANADA INC
Totals |
||
Shortage reports |
82 |
|
Actual shortage: | 1 (1%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 6 (7%) | |
Resolved: | 75 (91%) | |
Discontinuation Reports |
5 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 5 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2022-05-13 | 2023-03-24 | 160528 |
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-11 | 160531 |
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2022-06-03 | 2022-09-09 | 161863 |
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2022-10-03 | 2022-11-01 | 170954 |
OMNIPAQUE 240 | 518MG | SOLUTION | Avoided shortage | 2022-11-30 | 2023-01-25 | 176387 |
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2023-04-04 | 2023-04-14 | 188698 |
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-01-26 | 2024-02-13 | 217288 |
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-03-11 | 2024-04-02 | 221863 |
OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-04-23 | 2024-05-04 | 225946 |
VISIPAQUE 270 | 550MG | SOLUTION | Resolved | 2021-09-03 | 2021-09-09 | 145158 |
VISIPAQUE 270 | 550MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160506 |
VISIPAQUE 270 | 550MG | SOLUTION | Resolved | 2022-05-27 | 2023-01-05 | 161439 |
VISIPAQUE 270 | 550MG | SOLUTION | Resolved | 2022-05-27 | 2023-01-30 | 161445 |
VISIPAQUE 270 | 550MG | SOLUTION | Resolved | 2022-06-03 | 2023-02-07 | 161852 |
VISIPAQUE 270 | 550MG | SOLUTION | Resolved | 2024-05-06 | 2024-05-18 | 227151 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2021-08-18 | 2021-08-25 | 144299 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-04-01 | 2022-04-19 | 157813 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-12 | 2023-03-01 | 160389 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-07 | 160534 |
OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-17 | 160537 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
OMNISCAN | 287MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-25 | 182742 |
Metastron | 37 MBq/mL | Solution | Discontinued | 2018-10-12 | 2019-02-01 | 63929 |
THALLOUS CHLORIDE TI 201 INJECTION | 37MBq | SOLUTION | Discontinued | 2020-12-04 | 2021-06-05 | 129592 |
OMNIPAQUE 180 | 388MG | SOLUTION | Discontinued | 2023-01-31 | 2023-02-22 | 182757 |
OMNIPAQUE 240 | 518MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-18 | 182760 |
Showing 1 to 5 of 5